Medical Device News Magazine

Thursday, March 30, 2023

Health at Scale Awarded Patent for Breakthrough AI Technology for Smart Hyper-Personalized Provider Navigation

Awarded patent by USPTO for technology innovations in AI-guided provider search for primary and specialist care to optimize PCP assignment and drive smart specialist referrals

Health at Scale, the market leader in smart AI-powered technologies to optimize care management, announced today that it has been awarded a patent by the U.S. Patent and Trademark Office for its breakthrough advances in personalized patient-provider matching using machine learning.

Choosing a provider is often the most important decision a patient makes. Health at Scale’s patented technology transforms provider search by empowering patients to find optimal primary and specialist care provider matches specific to their unique individualized health conditions and needs. This represents a significant advancement over current navigation technologies that consider providers in isolation of the patient – and are typically based on ad-hoc reputation scores or process-based metrics that are not correlated with better outcomes.

Health at Scale’s invention uses new AI technologies to score patient-provider matches based on thousands of health factors about a patient and an understanding of which providers have historically done well with similar kinds of patients. This proprietary approach, offering smart hyper-personalized provider navigation to payers, employers, providers and patients, evaluates the best facility, practice and physician choices for each individual’s unique health situation, and enables the creation of deeply personalized networks for the N-of-1. Health at Scale’s novel approach uses advanced machine learning to simultaneously construct and relate information across multiple models that evaluate the best providers for each individual based on a vast number of factors related to the patient, provider, the time and setting.

This patent advances Health at Scale’s mission to re-invent care delivery as a precise and personalized process that is deeply aware of each patient’s unique health characteristics and circumstances at all times. By rethinking the patient-provider matching process, Health at Scale drives improved outcomes, costs, satisfaction, quality and equity, while reducing unnecessary waste and cost in the system.

“Putting each patient’s needs at the center of care management is a core element of our work at Health at Scale. We’re excited to lead the way in reimagining the how patients find providers: as a process that is built around each patient and shows a nuanced understanding and deep empathy for their unique needs in the moment,” said Zeeshan Syed, Health at Scale CEO and formerly a Clinical Associate Professor at Stanford Medicine and an Associate Professor with Tenure in Computer Science at the University of Michigan. “We’re proud of the recognition from the USPTO for our team’s thought-leadership and pioneering contributions in personalized navigation and are committed to continued innovation for the populations we serve.”

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

U.S. Department of Defense Awards Theradaptive $4 Million Contract for Its OsteoAdapt Regenerative Therapeutic Program

The funds from the DOD contract will enable Theradaptive to continue its work to meet regulatory requirements and scale up Good Manufacturing Practices-compliant manufacturing of the OsteoAdapt product in preparation for clinical studies.

Macrolux Completes Nearly CNY100 million Series A Round: Funding Led by Legend Capital

Legend Capital has long been paying attention to the investment in the field of medical devices and diagnostics with a focus on three major themes: first, major diseases, especially the unmet clinical needs of chronic diseases; second, the first and uniqueness in technology, which enables a company to become or have the potential to become a leading player in subdivided industries; the third is the "device +" investment opportunities brought by the integration of medical devices and interdisciplinary technologies such as AI, IoT and Big Data.

Previa Medical Raises €2.1 Mil for AI Solution to Prevent Sepsis

Sepsis is one of the leading causes of hospital deaths worldwide, with a 30-day mortality rate of 20 to 30%. SEPSI-SCORE therefore provides a much-needed solution to a major global public health issue.
Subscribe to Medical Device News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy